SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-046574
Filing Date
2023-09-06
Accepted
2023-09-06 08:55:12
Documents
13
Period of Report
2023-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20230831.htm   iXBRL 8-K 61387
2 EX-10.1 fgen-ex10_1.htm EX-10.1 99016
  Complete submission text file 0000950170-23-046574.txt   290083

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20230831_pre.xml EX-101.PRE 9900
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20230831_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20230831.xsd EX-101.SCH 2469
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20230831_htm.xml XML 4673
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 231237943
SIC: 2834 Pharmaceutical Preparations